Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy

被引：31
|
作者：
Siqueira, Rubens C.
Costa, Rogerio A.
Scott, Ingrid U.
Cintra, Lessia P.
Jorge, Rodrigo
机构：
[1] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Ophthalmol, Retina & Vitreous Sect, BR-14049900 Sao Paulo, Brazil
[2] Hosp Eye, Retinal & Vitreous Specialized Ctr, CERV, Sao Paulo, Brazil
[3] Hosp Olhos Araraquara, Retina Diagnost & Treatment Div, Sao Paulo, Brazil
[4] Penn State Univ, Coll Med, Dept Ophthalmol, Hershey, PA USA
来源：
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2006年 / 84卷 / 06期
关键词：
D O I：
10.1111/j.1600-0420.2006.00779.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：834 / 835
页数：3
相关论文
共 50 条
  • [21] Intravitreal Bevacizumab (Avastin) Injection in Retinitis Pigmentosa
    Yuzbasioglu, Erdal
    Artunay, Ozgur
    Rasier, Rifat
    Sengul, Alper
    Bahcecioglu, Halil
    CURRENT EYE RESEARCH, 2009, 34 (03) : 231 - 237
  • [22] Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
    Avery, Robert L.
    Pearlman, Joel
    Pieramici, Dante J.
    Rabena, Melvin D.
    Castellarin, Alessandro A.
    Nasir, Ma'an A.
    Giust, Matthew J.
    Wendel, Robert
    Patel, Arun
    OPHTHALMOLOGY, 2006, 113 (10) : 1695 - 1705
  • [23] Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma
    Yazdani, Shahin
    Hendi, Kamran
    Pakravan, Mohammad
    JOURNAL OF GLAUCOMA, 2007, 16 (05) : 437 - 439
  • [24] Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
    Ng, Wei Loon
    Trinavarat, Adisak
    Atchaneeyasakul, La-ongsri
    BMC PEDIATRICS, 2024, 24 (01)
  • [25] Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
    El-Batarny, Ashraf M.
    CLINICAL OPHTHALMOLOGY, 2007, 1 (02): : 149 - 155
  • [26] Clinical and histological findings after intravitreal injection of bevacizumab (Avastin®) in a porcine model of choroidal neovascularization
    Lassota, Nathan
    Prause, Jan Ulrik
    Scherfig, Erik
    Kiilgaard, Jens Folke
    la Cour, Morten
    ACTA OPHTHALMOLOGICA, 2010, 88 (03) : 300 - 308
  • [27] Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization
    Mandal, S.
    Venkatesh, P.
    Sampangi, R.
    Garg, S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (04) : 620 - 626
  • [28] Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation
    Ghazi, Nicola G.
    Knape, Robert M.
    Kirk, Tyler Q.
    Tiedeman, James S.
    Conway, Brian P.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (05): : 689 - 695
  • [29] Electrophysiological Assessment of Optic Nerve and Retinal Functions Following Intravitreal Injection of Bevacizumab (Avastin)
    Macky, Tamer A.
    Mahgoub, Mohamed M.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (02) : 159 - 165
  • [30] Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
    Arevalo, J. F.
    Maia, M.
    Flynn, H. W., Jr.
    Saravia, M.
    Avery, R. L.
    Wu, L.
    Farah, M. Eid
    Pieramici, D. J.
    Berrocal, M. H.
    Sanchez, J. G.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (02) : 213 - 216
12345